Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
11/2007
11/22/2007US20070269448 Transition State Analog Inhibitors Of Ricin A-Chain
11/22/2007CA2651453A1 5'-modified bicyclic nucleic acid analogs
11/21/2007EP1857461A1 Linker compound, probe, and carrier having probe immobilized thereon
11/21/2007CN101076535A Difluoronucleosides and process for preparation thereof
11/21/2007CN101074228A Method for preparing medicine composition containing 1,3-oxathin cyclopentane nucleoside analogues
11/21/2007CN100350052C Method of preparing a guanosine-group compound and an intermediate thereof
11/21/2007CN100349913C 2'-fluoronucleosides
11/20/2007US7297787 E.g., (2S, 3S, 4R, 5R)-2-(5-tert-butyl-[1,3,4]oxadiazol-2-yl)-5-[6-(4-chloro-2-fluoro-phenylamino)-purin-9-yl]-tetrahydro-furan-3,4-diol, by aminating a 6-halopurine ribofuranose nucleoside in the presence of CaCO3 , wherein acid is added to the reaction mixture.
11/20/2007US7297683 Crystalline forms of an antiviral benzimidazole compound
11/20/2007US7297509 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
11/20/2007CA2287838C Radionuclide associated with nucleotide polyphosphate as tumor imaging agents
11/20/2007CA2171743C Nucleotide analogs
11/15/2007WO2007129083A1 Anti-viral pyrimidine nucleoside derivatives
11/15/2007WO2007128874A1 Biomolecule labeling reactants based on azacycloalkanes and conjugates derived thereof
11/15/2007WO2007095269A3 Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
11/15/2007WO2007047572A3 Methods for identifying multiple dna alteration markers in a large background of wild-type dna
11/15/2007US20070265440 Synthesis of 2-alkynyladenosine derivatives eg Trans-(1-[4-hydroxymethyl)cyclohexyl]methyl)-4-methylbenzenesulfonate
11/15/2007US20070265224 Nucleotide mimics and their prodrugs
11/15/2007US20070265222 Nucleoside Aryl Phosphoramidates for the Treatment of Rna-Dependent Rna Viral Infection
11/15/2007US20070265198 Nucleic Acids and Polypeptides of C1 Bacteriophage and Uses Thereof
11/15/2007CA2656780A1 Anti-viral pyrimidine nucleoside derivatives
11/14/2007EP1853618A1 Tricyclic-nucleoside compounds for treating viral infections
11/14/2007EP1853617A1 Tricyclic-nucleoside prodrugs for treating viral infections
11/14/2007EP1853616A1 Intermediate and process for preparing of beta-anomer enriched 21-deoxy,21,21-difluoro-d-ribofuranosyl nucleosides
11/14/2007EP0927189A4 Processes for high-yield diastereoselective synthesis of dideoxynucleosides
11/14/2007CN101072787A Substituted adenines and the use thereof
11/14/2007CN101072570A Methods and compositions for treating flaviviruses, pestiviruses and hepacivirus
11/14/2007CN101070336A Polycarboxy-heterocyclic-ketene-aminal mucleosides analogs and its preparing method
11/13/2007US7294621 Lipid analogs for combating tumors
11/13/2007US7294620 Lipid analogs for inhibiting HIV-1 activity
11/13/2007US7294619 Treating hepatitis B viral infections by administering a phospholipid choline derivative, e.g., 1-dodecanamido-2-decyloxypropyl-3-phosphocholine
11/13/2007US7294486 Using streptomyces fluorinase to generate 5'-fluoro-5'-deoxyadenosine or fluoroacetate for use as tumor imaging agent
11/13/2007US7294467 Filtering a nucleic acid to remove other phosphorous-containing compounds; digesting the nucleic acid with an acid; quantifying phosphorous content in the sample using inductively coupled plasma-optical emission spectrometry; and calculating quantity of said nucleic acid from the quantity of phosphorus
11/13/2007CA2402707C Use of cdp-choline for the treatment of alcohol withdrawal syndrome
11/13/2007CA2258243C 4,7-dichlororhodamine dyes
11/08/2007WO2007125173A2 Antisense agents combining strongly bound base - modified oligonucleotide and artificial nuclease
11/08/2007WO2007084157A3 Nucleoside prodrugs for treating viral infections
11/08/2007WO2007070598A9 Nucleotide and oligonucleotide prodrugs
11/08/2007WO2006084067A3 Dark quenchers, probes and other conjugates incorporating the same, their use
11/08/2007US20070261131 Producing a drought-tolerant transgenic plant; transforming a plant cell with an expression vector comprising a polynucleotide encoding a polypeptide; growing the transformed plant cell to generate transgenic plants; screening
11/08/2007US20070259832 Nucleotide mimics and their prodrugs
11/08/2007CA2650820A1 Use of base-modified deoxynucleoside triphosphates to improve nucleic acid detection
11/07/2007EP1852439A1 Spiroketal derivative and use thereof as diabetic medicine
11/07/2007EP1852121A2 Lipid analogs for treating viral infections
11/07/2007EP1257281B1 Nucleoside analogs with carboxamidine modified monocyclic base
11/07/2007EP1047704B2 Method for producing fludarabin phosphate lithium, sodium, potassium, calcium and magnesium salts, purification method for producing fludarabin phosphate and fludarabin phosphate which is at least 99.5 % pure
11/07/2007CN101068825A 2-propynyl adenosine analogs with modified 5'-ribose groups having A2A agonist activity
11/07/2007CN101068820A Non-hygroscopic and powdery amorphous pimecrolimus
11/07/2007CN101068819A Processes for producing crystalline macrolides
11/07/2007CN101068818A Methods of preparing pimecrolimus
11/07/2007CN101066987A Prepn process of brivudine
11/07/2007CN101066970A Method for preparing medicine composition containing 1,3 oxathiolane nucleoside analogue
11/07/2007CN101066276A Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
11/07/2007CN100347185C Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same
11/06/2007US7291726 Halogenating an L-arabinose; reducing the product and halogenating to form a 2-deoxy-2-halo-L-arabinopyranose, which is converted with an acid to form a 1-O-alkyl-2-deoxy-2-halo-L-arabinofuranose; replacing the 1-O-alkyl group with a halogen; and coupling the arabinofuranose to a nucleoside base
11/06/2007US7291673 Polymeric biomaterials formed by nucleophilic addition reactions to conjugated unsaturated groups
11/06/2007US7291606 Compositions and methods for identifying agents which regulate chromosomal stability, gene activation and aging
11/06/2007US7291603 Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations
11/06/2007US7291463 Incubating/condensating pseudoisocytidine molecule with (1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride to provide a pseudouridine molecule; oncology diagnosis
11/01/2007WO2007122333A2 Process for preparing disulphides and thiosulphinates and compounds prepared
11/01/2007WO2007121883A2 1,4:3,6-dianhydromannitol derivatives and use thereof
11/01/2007WO2007090553A3 Compounds useful as agonists of a2a adenosine receptors, cosmetic compositions with a2a agonists and a method for using the same
11/01/2007WO2006062434A8 Modified 5'- phosphonate azidothymidine-potential anti-viral preparations
11/01/2007US20070255045 O-acetyl-ADP ribose, a histone deacetylase-reaction product, used for producing polyclonal or monoclonal antibodies, and for analysis by competitive binding assaying of aging resistance and/or anticarcinogenic agents
11/01/2007US20070254851 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
11/01/2007US20070254298 Atropisomers of asymmetric xanthene fluorescent dyes and method of dna sequencing and fragment analysis
11/01/2007CA2650186A1 Process for preparing disulphides and thiosulphinates and compounds prepared
11/01/2007CA2649215A1 2,6,9-trisubstituted purine compounds as adenosine aza receptor modulators
11/01/2007CA2649205A1 Organic compounds
10/2007
10/31/2007CN101062928A Process for preparing 2-pyrrolidinyl-1h-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside metabolism
10/30/2007CA2355816C A system and methods for nucleic acid sequencing of single molecules by polymerase synthesis
10/25/2007WO2007119815A1 Toll-like receptor 9 agonists
10/25/2007WO2007119624A1 Nucleoside derivative having antiherpesvirus activity
10/25/2007WO2007020457A3 Labelled modified guanine- containing nucleosides and nucleotides comprising a fluorophore attached to the base through a linking group comprising a polyethylene glycol spacing group and methods for their use
10/25/2007WO2007020193A3 Antiviral phosphoramidates of 4 ' -substituted pronucleotides
10/25/2007US20070250962 Nucleotide Sequences and Polypeptides Encoded Thereby Useful for Increasing Plant Size and Increasing the Number and Size of Leaves
10/25/2007US20070250959 Maize promoter active in silks, stalk nodes, roots and leaf sheaths
10/25/2007US20070250956 modulating expression of a GATA transcription factor gene in the plant cell; modulates agronomic traits such as improved fertilizer untilization (nitrogen utilization), crop yield, lipid biosynthesis
10/25/2007US20070250948 Vectors useful in plant transformations; useful for transferring and integrating one polynucleotide into another via bacterial-mediated transformation
10/25/2007US20070249823 Process for preparing gemcitabine and associated intermediates
10/25/2007US20070249822 Photolabile Coumarinylmethyl Esters of Cyclic Nucleotides, Methods for their Preparation and Their Use
10/25/2007US20070249818 Method for the Preparation of 2'-Deoxy-2',2'-Difluorocytidine
10/25/2007US20070249548 Nucleoside Analog or Salts of the Same
10/25/2007US20070249049 For modulating gene expression pathways, including those relying on mechanisms of action such as RNaseH, RNAi and dsRNA enzymes, as well as other antisense mechanisms based on target degradation or target occupancy; of therapeutic, diagnostics, and research applications; nuclease resistance
10/25/2007DE102007018551A1 Verfahren zur Herstellung von Gemcitabin und verwandten Intermediaten A process for preparing gemcitabine and related intermediates
10/24/2007EP1847547A1 Anti-wrinkle cosmetic composition
10/24/2007EP1847546A1 Imidazopyridine derivative
10/24/2007EP1846034A2 Agents and methods related to reducing resistance to apoptosis-inducing death receptor agonists
10/24/2007CN101061131A Gemcitabine derivatives nanoparticles
10/24/2007CN100344645C Process for purifying oligonucleotide synthons
10/24/2007CN100344644C Improved method for synthesizing PET developer labeled precursor thymidine derivative
10/23/2007US7285660 Process for the preparation of L-ribavirin
10/23/2007US7285659 Process for the preparation of D-ribavirin
10/23/2007US7285658 For the treatment of viral infections, microbial infections, and proliferative disorders; contain di- or triphosphate moeity mimetics, such as those containing boron anions
10/23/2007US7285622 Hydrophilic polymer covalently yet reversibly linked to a amine-containing ligand through a dithiobenzyl linkage; modification of various substrates, such as polypeptides
10/23/2007US7285551 For use as therapeutic agent and prophylactic agent for hepatitis C
10/23/2007US7285242 Apparatus for use in the detection of signal form radioactive particles
10/23/2007CA2340156C .beta.-l-2'-deoxy-nucleosides for the treatment of hepatitis b
10/18/2007WO2007117760A2 Preparation of gemcitabine
10/18/2007WO2007116731A1 Composition containing reduced coenzyme a
1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 201